Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Preclinical Evaluation of TMC-278 LA,a Long-acting Formulation of Rilpivirine,Demonstrates Significant Protection from Vaginal HIV Infection